Fast shipping in Europe & USA
- Made in ISO 9001:2015 certified lab
- info@domain.com
€105,00
VISA, APPLEPAY, GPAY
Hassle-free returns within 30 days
Guaranteed quality
We’re here anytime
From €130
Retatrutide may well be the most advanced peptide in its class to date. Earlier compounds GLP-1 agonists like Semaglutide and dual agonists such as Tirzepatide have already reshaped research into weight loss and type 2 diabetes. Retatrutide takes that a step further.
This is a triple agonist, targeting three key metabolic receptors GLP-1, GIP, and glucagon. Together, these pathways regulate appetite, stabilise blood sugar, and optimise how the body uses energy. In simple terms? Better fat metabolism, improved glucose control, and more efficient energy use.
Early research has delivered standout results, with studies showing average weight loss of up to 24% of total body weight. That alone makes Retatrutide one of the most exciting compounds currently under investigation. But the potential doesn’t stop there future research is already exploring its role in cardiovascular health, inflammation, and broader metabolic conditions.
This is not just another peptide. It’s a major step forward in how metabolic dysfunction is understood and studied.
Interest in Retatrutide is growing fast and with that comes a rise in low quality suppliers. In research, that is a risk you cannot take.
CellPeptides provides reliable, research grade Retatrutide you can trust for serious scientific work.
With us, you get
• ≥99 percent purity with pharmaceutical grade quality
• Third party lab testing with full certificates of analysis
• Fast insured global shipping with full tracking
• Responsive support from a team that understands peptide research
We are not just a supplier. We are a research focused company ready to support your work when it matters most.
Retatrutide works by activating three metabolic pathways at once, something no earlier compound has achieved this effectively.
GLP 1 receptor
Helps regulate blood sugar, reduces appetite, and increases satiety
GIP receptor
Supports insulin release and may influence how the body stores fat
Glucagon receptor
Increases energy expenditure and promotes fat breakdown
This combined action creates a powerful metabolic response that targets appetite, glucose control, and fat metabolism at the same time.
Instead of focusing on one pathway, Retatrutide works across the full system. That is what makes it so effective.
Retatrutide is still relatively new, but the research so far has been extremely promising. The results go beyond what is typically seen with metabolic compounds.
Clinical trials have shown average weight loss exceeding 20 percent, with some results reaching around 24 percent. These outcomes were previously only possible through surgical interventions.
Studies show strong improvements in glucose regulation, including reductions in HbA1c and improved insulin sensitivity without the same risks seen in older treatments.
Research has shown major reductions in liver fat, suggesting potential applications in conditions like non alcoholic fatty liver disease.
Retatrutide directly impacts satiety signals in the brain, helping reduce hunger and support more balanced eating patterns.
Early findings suggest improvements in blood pressure, cholesterol, and overall cardiovascular risk markers, making this an important area for future study.
Retatrutide is especially relevant for researchers working in
• Obesity and weight loss
• Type 2 diabetes and glucose metabolism
• Liver health and metabolic disease
• Cardiovascular risk and inflammation
• Comparative studies with existing metabolic peptides
If your research focuses on metabolic optimisation or chronic disease, Retatrutide is worth serious attention.
Dosing depends on the study design and model. Current research trends suggest
• Starting doses between 1 and 4 mg
• Gradual increases of 0.5 to 1 mg over time
• Maintenance doses reaching up to 12 mg in advanced studies
For preparation
Reconstitute lyophilised Retatrutide with around 2 mL of bacteriostatic water
Store at temperatures between 2 and 8°C for multi dose use
Use within 30 to 60 days and discard if the solution becomes cloudy
Accurate dosing always depends on your specific model and research goal.
Is Retatrutide more effective than earlier GLP 1 compounds
Early research suggests stronger results in both weight loss and glucose control due to its triple receptor action.
What makes it different from dual agonists
Retatrutide activates an additional pathway, which enhances energy use and fat metabolism.
Does it have anti inflammatory potential
Initial findings suggest reduced inflammation markers, but more research is needed to confirm direct effects.
How quickly are effects observed
Appetite changes may appear quickly, while metabolic improvements and weight loss develop over weeks to months.
